On February 21, 2019 UroGen Pharma Ltd. (Nasdaq:URGN) reported that it will report fourth quarter and full year 2018 financial results on Thursday, February 28, 2019, prior to the open of the market (Press release, UroGen Pharma, FEB 21, 2019, View Source;p=RssLanding&cat=news&id=2388360 [SID1234533532]). The announcement will be followed by a live audio webcast and conference call at 8:30AM Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Audio Webcast

The webcast will be made available on the Investors section of the Company’s website at View Source Following the live audio webcast, a replay will be available on the Company’s website for approximately two weeks.

Dial-In Information

Live (U.S. / Canada): 1 (888) 771-4371
Live (International): 1 (847) 585-4405
Confirmation number: 48205742